Nuformix CEO stands down

Pharmaceutical company Nuformix revealed on Monday that chief executive Dr Dan Gooding had stood down from the company's board of directors with immediate effect.

Nuformix said that chairman Dr Christopher Blackwell will lead the company as executive chairman until a suitable successor can be found. Gooding will stay on until the end of June to conduct an orderly handover.

Gooding said: "We set up what is now Nuformix twelve years ago. To have been involved at its heart as a co-founder from the first day through to listing on the main market and beyond has been an enormous privilege and I am immensely proud of all that we have achieved.

"Now is the right time for me to step aside and move on to other projects. The company has multiple exciting opportunities ahead and I wish the team and the business every success."

As of 1330 BST, Nuformix shares were down 5.25% at 4.12p.